Anne L. Taylor

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure

Anne L. Taylor, Susan Ziesche, Clyde W. Yancy et al. · New England Journal of Medicine · 2004 · 1.8K citations

Medicine, Cardiology, Pharmacology +10

Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women

Lori Mosca, Lawrence J. Appel, Emelia J. Benjamin et al. · Circulation · 2004 · 922 citations · Full text

Medicine, Cardiology, Preventive Medicine +14

A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer.

Afshin Dowlati, Kelly M. Robertson, Matthew M. Cooney et al. · PubMed · 2002 · 406 citations

Medicine, Oncology, Pharmacology +17

Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators.

Paolo Golino, J H Ashton, L. Maximilian Buja et al. · Circulation · 1989 · 215 citations

Medicine, Cardiology, Hematology +12